Abstract:Objective To explore the prevalence and influencing factors of depression and anxiety in breast cancer patients in Xinjiang. Methods We selected all breast cancer patients hospitalized in the Third Affiliated Hospital of Xinjiang Medical University from January to December, 2018 to serve as the research subjects. Self-Rating Depression Scale and Self-RatingAnxiety Scale were used to conduct a cross-sectional survey. The prevalence of depression and anxiety in the breast cancer patients was evaluated, and a binary logistic regression model was applied to analyzing the factors influencing depression or anxiety among the breast cancer patients. Results Among the 461 breast cancer patients, there were 197 (42.73%) patients having depression, of which mild, moderate and severe depression patients accounted for 31.67% (146/461), 9.54% (44/461) and 1.52% (7/461), respectively. There were 240 (52.06%) patients with anxiety, of which mild, moderate and severe anxiety patients accounted for31.67% (146//461), 13.88% (64/461) and 6.51% (30/461), respectively. Multivariate analysis results revealed thathaving no chemotherapy (OR=0.355, 95%CI:0.165-0.761), having a lower income (OR=9.211, 95%CI:3.303-25.685), having a shorter disease duration (OR=7.716, 95%CI:1.773-33.577) and physical exercise per week ≤150minutes (OR=2.718, 95%CI:1.777-4.155) were the factors influencing depression among the breast cancer patients. Rural registered permanent residence (OR=1.835, 95%CI:1.142-2.957), having a shorter disease duration (OR=2.208, 95%CI:1.377-3.541) and physical exercise per week ≤150 minutes (OR=1.939, 95%CI:1.303-2.886) were the factors influencing anxiety among the breast cancer patients (all P<0.05). Conclusion The prevalence rates of depression and anxiety in the female breast cancer patients in Xinjiang are relatively high. Intervention measures should be actively taken to reduce the occurrence of negative emotions such as depression and anxiety and improve the patients’ quality of life and prognoses.
[1] Ginsburg O,Bray F,Coleman MP,et al.The global burden of women's cancers:a grand challenge in global health[J]. Lancet, 2017,389(10071):847-860. [2] Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study[J]. JAMA Oncol,2019,5(12): 1749-1768. [3] Bray F,Ferlay J,Soerjomataram I,et al. Global cancer statistics 2018: GLOBOC an estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. [4] 杜建艳,潘文颖,王承展,等.乳腺癌合并抑郁症的病因机制及其治疗进展[J].国际精神病学杂志,2019,46(5):784-786. [5] 葛红敏. ZUNG氏抑郁自评量表(SDS)作为住院患者抑郁障碍常规筛查工具的可行性研究[D].济南:山东大学, 2008. [6] Dunstan DA, Scott N.Clarification of the cut-off score for Zung's Self-Rating Depression Scale[J]. BMC Psychiatry, 2019, 19(1):177. [7] Zung W. A rating instrument for anxiety disorders[J]. Psychosomatics,1971,12(6): 371-379. [8] 卞绿,臧娅,赵丽华.乳腺癌患者的焦虑、抑郁情绪和生存质量的相关性研究[J].实用预防医学,2021,28(12):1529-1532. [9] Purkayastha D,Venkateswaran C,Nayar K,et al. Prevalence of depression in breast cancer patients and its association with their quality of life: a cross-sectional observational study[J]. Indian J Palliative Care,2017,23(3):268-273. [10] Jiayuan Z, Yuqiu Z, Ziwei F, et al. Longitudinal trends in anxiety, depression, and quality of life during different intermittent periods of adjuvant breast cancer chemotherapy[J]. Cancer Nurs, 2018,41(1):62-68. [11] Yang YL,Liu L,Wang Y, et al.The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis[J]. BMC Cancer,13,1(2013-08-22), 2013,13(1):393. [12] Hong JS,Tian J.Prevalence of anxiety and depression and their risk factors in Chinese cancer patients[J].Support Care Cancer,2014,22(2):453-459. [13] Pilevarzadeh M,Amirshahi M,Afsargharehbagh R,et al. Global prevalence of depression among breast cancer patients:a systematic review and meta-analysis[J].Breast Cancer Res Tr, 2019, 176(3):519-533. [14] Hashemi SM,Rafiemanesh H, Aghamohammadi T,et al. Prevalence of anxiety among breast cancer patients:a systematic review and meta-analysis[J]. Breast Cancer,2020,27(2):166- 178. [15] Wang X,Zhang Y,Fan Y,et al. Effects of music intervention on the physical and mental status of patients with breast cancer: a systematic review and meta-analysis[J].Breast Care (Basel), 2018,13(3):183-190. [16] 徐娜,孙涛.中西医治疗乳腺癌并发抑郁症的研究进展[J].中外医学研究,2020,18(11):186-188. [17] Champion VL,Wagner LI,Monahan PO,et al. Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains[J]. Cancer, 2014,120(15):2237-2246. [18] 杨柠溪,饶翮,许亚运,等.癌症患者社会资本对抑郁情绪的影响[J].中华行为医学与脑科学杂志,2015,24(9):820-823. [19] Hellstadius Y,Lagergren P,Lagergren J,et al. Aspects of emotional functioning following oesophageal cancer surgery in a population based cohort study [J].Psychooncology,2015,24 (1):47-53. [20] Oerlemans S,Mols F,Nijziel MR,et al. The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry[J].J Cancer Surviv,2014,8(4):555-564. [21] Zainal NZ, Nik-Jaafar NR, Baharudin A,et al.Prevalence of depression in breast cancer survivors: a systematic review of observational studies[J].Asian Pac J Cancer Prev, 2013, 14(4):2649-2656. [22] Berhili S,Kadiri S,Bouziane A,et al.Associated factors with psychological distress in Moroccan breast cancer patients: a cross-sectional study[J].Breast,2017,31:26-33. [23] Srivastava V,Ansari MA,Kumar A,et al.Study of anxiety and depression among breast cancer patients from North India [J].Clin Psych, 2015,2(9):1-7. [24] 童兆莹.乳腺癌患者抑郁相关因素分析[J].临床护理杂志,2017,16(1):11-14. [25] Tsaras K,Papathanasiou IV,Mitsi D,et al.Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors[J].Asian Pac J Cancer Prev, 2018, 19(6):1661-1669.